A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma

Tamara J. Dunn, Shira Dinner, Elizabeth Price, Steven E. Coutré, Jason Gotlib, Ying Hao, Caroline Berube, Bruno C. Medeiros, Michaela Liedtke*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences